Prokidney to participate in fireside chat at the jefferies healthcare conference

Winston-salem, n.c., june 01, 2023 (globe newswire) -- prokidney corp. (nasdaq: prok) (“prokidney” or the “company”), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (ckd), today announced that dr. tim bertram, chief executive officer, will participate in a fireside chat at the jefferies healthcare conference, being held in new york, ny from june 7 – 9, 2023.
PROK Ratings Summary
PROK Quant Ranking